home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Small Drug Blocks Cancer-Related Pathway

  September, 17 2009 9:24
your information resource in human molecular genetics

A small molecule that blocks the activity of a signalling pathway implicated in many cancers is revealed in Nature. The study, by Feng Cong and colleagues, provides new insights into how the Wnt pathway operates, as well as the development of Wnt-targeted cancer drugs.

The drug, called XAV939, disrupts Wnt pathway signalling, and its target and mechanism of action are described. The Wnt pathway is well known for its roles in embryonic development and adult physiology, and abnormal Wnt activity has been implicated in many cancers. But the scarcity of 'druggable' targets in the pathway has hampered the development of Wnt-blocking therapies. The discovery of this low molecular mass Wnt inhibitor opens the door for a new way to combat cancer.


Feng Cong (Novartis Institutes for Biomedical Research, Cambridge, MA, USA)
Email: feng.cong@novartis.com

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.